Portolan Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-61,583
Closed -$4.34M 155
2022
Q3
$4.34M Sell
61,583
-70,596
-53% -$6.04M 0.46% 81
2022
Q2
$9.38M Buy
132,179
+20,381
+18% +$1.31M 0.94% 41
2022
Q1
$8.93M Buy
+111,798
New +$8.33M 0.71% 57

Other funds holding STAA

Portolan Capital Management's STAA Position: Q4 2022 in Review

Portolan Capital Management sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 61,583 shares — an estimated $4.34M sold.

Portolan Capital Management first reported a position in STAA in Q1 2022 and held it in 3 quarters. The position peaked at $9.38M in Q2 2022. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • Portolan Capital Management reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • Portolan Capital Management sold 61,583 STAAR Surgical shares in Q4 2022, an estimated $4.34M.
  • Portolan Capital Management first reported a position in STAAR Surgical in Q1 2022 and held it in 3 quarters.
  • Portolan Capital Management's STAAR Surgical position peaked at $9.38M in Q2 2022.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Portolan Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.